Tim Xu discusses new data from Amplyx
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.
Who are the women blazing trails in biopharma R&D and leading the fight against Covid-19?
Optimum aims to provide you with the most informative insights on the current COVID-19 pandemic. The below renowned publications are striving to provide the best and most timely research, analysis, and news coverage of COVID-19 and the coronavirus that causes it. All content is currently free to access and is available at the below links. […]
By Aleks Engel, Partner, Novo Holdings (Novo Seeds) and Director, REPAIR Impact Fund